MTCO2P12 and familial pancreatic carcinoma: In pancreatic cancer patients, an intake of 8 g/day of curcumin for two months resulted in a significant downregulation of pro-inflammatory and pro-survival signals, including NF-κB, COX-2, and STAT3, in peripheral blood mononuclear cells (PBMCs) [93].